Agilon Health (AGL) Cost of Revenue (2020 - 2026)

Agilon Health (AGL) has reported Cost of Revenue for 7 consecutive years, with $367.7 million the latest figure, recorded in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $367.7 million, up 914.56% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 billion (up 121.17% YoY), and the FY2025 annual result was $6.0 billion, up 74623.82% from the prior year.
• Cost of Revenue was $367.7 million for Q1 2026 at Agilon Health, down from $5.9 billion in the prior quarter.
• Over five years, Cost of Revenue peaked at $5.9 billion in Q4 2025 and troughed at -$63.5 million in Q4 2024.
• Average Cost of Revenue over 5 years is $992.8 million, with a median of $367.7 million recorded in 2026.
• Year-over-year, Cost of Revenue slumped 101.61% in 2024 and jumped 9377.3% in 2025.
• Over 5 years, Cost of Revenue stood at $847.1 million in 2022, then surged by 364.85% to $3.9 billion in 2023, then plunged by 101.61% to -$63.5 million in 2024, then surged by 9377.3% to $5.9 billion in 2025, then tumbled by 93.76% to $367.7 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $367.7 million in Q1 2026, $5.9 billion in Q4 2025, and $33.7 million in Q3 2025.